Back
22nd Century Group Vs. Viking Therapeutics Industry Stock Comparison
Sell
16
XXII
22nd Century Group
Last Price:
0.74
Seasonality Move:
-12.13%
Sell
44
VKTX
Viking Therapeutics
Last Price:
52.96
Seasonality Move:
1.76%
Sell
16
22nd Century Group (XXII)
is a Sell
Is 22nd Century Group a Buy, Sell or Hold?
- The current 22nd Century Group [XXII] share price is $0.79. The Score for XXII is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
- XXII is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
44
Viking Therapeutics (VKTX)
is a Sell
Is Viking Therapeutics a Buy, Sell or Hold?
- The current Viking Therapeutics [VKTX] share price is $50.77. The Score for VKTX is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- VKTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
XXII Stock Price Chart
What is 22nd Century Group's stock price today?
-
The 22nd Century Group share price today is $0.79
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and XXII is experiencing slight buying pressure.
VKTX Stock Price Chart
What is Viking Therapeutics's stock price today?
-
The Viking Therapeutics share price today is $50.77
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
XXII Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.17 | Sell |
Relative Strength Index (14 RSI): | 41.81 | Sell |
Chaikin Money Flow: | 161260 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.63 - 1.09) | Sell |
Bollinger Bands (100): | (1.1 - 2.34) | Sell |
VKTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -4.32 | Sell |
Relative Strength Index (14 RSI): | 38.16 | Sell |
Chaikin Money Flow: | 2857375 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (50.57 - 61.31) | Sell |
Bollinger Bands (100): | (46.52 - 79.44) | Sell |
XXII Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.66 | Buy |
20-day SMA: | 0.75 | Buy |
50-day SMA: | 1.24 | Sell |
200-day SMA: | 4.4 | Sell |
8-day EMA: | 0.7 | Buy |
20-day EMA: | 0.81 | Sell |
50-day EMA: | 1.2 | Sell |
200-day EMA: | 23.43 | Sell |
VKTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 50.48 | Buy |
20-day SMA: | 54.1 | Sell |
50-day SMA: | 63.93 | Sell |
200-day SMA: | 39 | Buy |
8-day EMA: | 50.61 | Buy |
20-day EMA: | 54.34 | Sell |
50-day EMA: | 59.63 | Sell |
200-day EMA: | 45.62 | Buy |
22nd Century Group Earnings Growth & XXII Earnings Dates
- Analysts estimate an earnings increase this quarter of $15.19 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.44 per share, and an increase next year of $0.92 per share.
Viking Therapeutics Earnings Growth & VKTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.06 per share, an increase next quarter of $0.00 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.43 per share.
22nd Century Group Technical Analysis
Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Viking Therapeutics Technical Analysis
Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |